Adalton Ribeiro
www.linkedin.com
0000-0003-4994-4662
Brazilian Health Ministry
9 papers found
Refreshing results…
U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer
Pcn37 Fda New Drugs Approval for Breast, Colorectal, Prostate and Lung Cancer and Horizon Scanning Opportunity
Pro14 Comparar a Incidência De Comorbidades No Tratamentos De Mieloma Múltiplo Entre as Terapias Do Sistema De Saúde Brasileiro (Sus) Com as Ainda Não Incorporadas
Pcn66 Identification of Patients Undergoing Treatment of Lung Cancer in the Brazilian National Health System (Sus)
Psy146 - Serious Adverse Reactions Reported for Drugs Involved in Lawsuits Filed Against the Brazilian Public Health System
Psy144 - Drugs Involved in Lawsuits Filed Against the Unified Health System (Sus) in São Paulo - Brazil, in 2017
Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes
Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associations
Plasmodium falciparum: sequence diversity and antibody recognition of the Merozoite surface protein-2 (MSP-2) in Brazilian Amazonia
Missing publications? Search for publications with a matching author name.